Replies to post #41388 on Biotech Values

[daved]

Re MCU. What possible relevance does the absolute number of incidences have to do with the discussion?

The numbers have to be large to reach the significance numbers reported.

What is your source for the P2 mortality statement? I've not noticed it in the literature.

Dave

[iwfal]

From the Phase II 900 patient trial can you please explain how many patients would have had a peak CK-MB greater than or equal to 100ng/ml to put it in proper perspective and show why the failure of the primary endpt of 50ng/ml is significant?

The answer is about 50 in the placebo arm assuming it is 300 patients per arm.

FWIW. (and it was somewhere near 15 +/- 3 that had "physician diagnosed MI" in the placebo arm)